← All trials

NCT06213636

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jul 10, 2024
Primary completion
Feb 10, 2025
Completion date
Dec 10, 2025
First posted
Jan 19, 2024
Last posted
Nov 12, 2024
Enrollment
75
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.